Crossmark

Efficacy of intermediate-dose cytarabine in central nervous system-relapsed wild-type BRAF Erdheim-Chester disease

Crossref DOI link: https://doi.org/10.1007/s00277-017-3114-7

Published Online: 2017-08-23

Published Print: 2018-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cao, Xin-xin

Niu, Na

Sun, Jian

Zhou, Dao-bin

Li, Jian https://orcid.org/0000-0002-4549-0694
Funding

Funding for this research was provided by:

the CAMS Innovation Fund for Medical Sciences (2016-12M-1-002)

The National Key Research and Development Program of China (2016YFC0901503)
License Information

License valid from 2017-08-23